Charlottesville, VA, United States of America

Julien Dimastromatteo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Zielbio, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julien Dimastromatteo. Retrieved from https://idiyas.com/inventor/julien-dimastromatteo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Julien Dimastromatteo

Introduction

Julien Dimastromatteo is an accomplished inventor based in Charlottesville, VA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic agents.

Latest Patents

Julien holds 1 patent for his work on "Plectin-1 binding antibodies and uses thereof." This patent outlines compositions and methods for treating cancer characterized by surface expression of plectin-1. The disclosure includes anti-plectin-1 antibodies, which may be conjugated to a targeted moiety, such as a therapeutic agent or a detectable label.

Career Highlights

Julien has established himself as a key figure in the biotechnology sector. His work at Zielbio, Inc. has been instrumental in advancing cancer therapies. His innovative approach to targeting plectin-1 has opened new avenues for treatment options.

Collaborations

Julien collaborates with various professionals in the field, including his coworker Kimberly A Kelly. Their combined expertise enhances the research and development efforts at Zielbio, Inc.

Conclusion

Julien Dimastromatteo's contributions to cancer treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…